Is RDY or SBFM more undervalued in 2026?

CirclFi compares Dr. Reddy's Laboratories Ltd (RDY) and Sunshine Biopharma Inc. (SBFM) using 13 institutional-grade valuation models. RDY has a Quality of Company score of 9.0/10 while SBFM scores 5.8/10.

Which is a better buy — RDY or SBFM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RDY and SBFM valuations compare?

RDY at $13.52 and SBFM at $0.32 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RDY vs SBFM Valuation Comparison 2026 — Intrinsic Value Analysis

RDY

Drug Manufacturers - Specialty & Generic

Dr. Reddy's Laboratories Ltd

Quality

9.0

out of 10

Value Trap

SAFE

Price

$13.52

Last close

Models

13/13

Active

SBFM

Drug Manufacturers - Specialty & Generic

Sunshine Biopharma Inc.

Quality

5.8

out of 10

Value Trap

SAFE

Price

$0.32

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	RDY Fair Value	RDY Upside	SBFM Fair Value	SBFM Upside
Bayesian DCF	Intrinsic	$3.32	-75.4%	$0.31	-1.0%
Earnings Power Value	Intrinsic	$7.14	-47.2%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$13.85	+2.5%	$1.76	+453.6%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RDY vs SBFM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RDY vs SBFM — Which Stock Is More Undervalued?

RDY scores higher with a 9.0/10 quality rating vs SBFM's 5.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Dr. Reddy's Laboratories Ltd (RDY) and Sunshine Biopharma Inc. (SBFM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RDY currently trades at $13.52 with a QOC of 9.0/10, while SBFM trades at $0.32 with a QOC of 5.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).